Innovative Medicine — Additions to Property, Plant & Equipment
Johnson & Johnson Innovative Medicine — Additions to Property, Plant & Equipment decreased by 44.2% to $508.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 84.1%, from $276.00M to $508.00M. Over 4 years (FY 2021 to FY 2025), Innovative Medicine — Additions to Property, Plant & Equipment shows an upward trend with a 14.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher spending indicates investment in future production capacity or research capabilities, signaling growth expectations.
Detailed definition
This metric tracks the capital expenditures made to acquire or improve physical assets, such as manufacturing facilities...
Peer comparison
Comparable to 'Capital Expenditures' (CapEx) reported by peers for their pharmaceutical manufacturing and R&D divisions.
jnj_segment_innovative_medicine_additions_to_property_plant_equipmentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $299.50M | $299.50M | $299.50M | $343.50M | $343.50M | $343.50M | $343.50M | $413.25M | $413.25M | $413.25M | $413.25M | $232.00M | $321.00M | $418.00M | $739.00M | $276.00M | $411.00M | $479.00M | $910.00M | $508.00M |
| QoQ Change | — | +0.0% | +0.0% | +14.7% | +0.0% | +0.0% | +0.0% | +20.3% | +0.0% | +0.0% | +0.0% | -43.9% | +38.4% | +30.2% | +76.8% | -62.7% | +48.9% | +16.5% | +90.0% | -44.2% |
| YoY Change | — | — | — | — | +14.7% | +14.7% | +14.7% | +20.3% | +20.3% | +20.3% | +20.3% | -43.9% | -22.3% | +1.1% | +78.8% | +19.0% | +28.0% | +14.6% | +23.1% | +84.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's innovative medicine — additions to property, plant & equipment?
- Johnson & Johnson (JNJ) reported innovative medicine — additions to property, plant & equipment of $508.00M in Q1 2026.
- How has Johnson & Johnson's innovative medicine — additions to property, plant & equipment changed year-over-year?
- Johnson & Johnson's innovative medicine — additions to property, plant & equipment increased by 84.1% year-over-year, from $276.00M to $508.00M.
- What is the long-term trend for Johnson & Johnson's innovative medicine — additions to property, plant & equipment?
- Over 4 years (2021 to 2025), Johnson & Johnson's innovative medicine — additions to property, plant & equipment has grown at a 14.7% compound annual growth rate (CAGR), from $1.20B to $2.08B.
- What does innovative medicine — additions to property, plant & equipment mean?
- Capital spending on physical infrastructure and equipment for the pharmaceutical segment.